Summary of Purpose
The purpose of this study is to investigate the effect of taking multiple doses of BMS-986177 when aspirin is taken once-daily. Eligible participants will receive twice-daily doses of BMS-986177 or placebo, with a once-daily dose of aspirin. The safety, tolerability and movement of BMS-986177 into, through and out of the body (pharmacokinetics/PK) will be assessed, as will the effect of BMS-986177 on the PK of...Read More →
The following dates are available for this trial. Trial information last updated on 17 January 2018.
|18 Oct 2017||30 Oct 2017||16 Nov 2017||16 Nov 2017||1 Jan 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Bristol-Myers Squibb Lead
- First line of the email MUST contain NCT# and Site #
- Recruiting sites have contact information. Please contact sites directly. If there is no contact information, please